Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion type Assertion NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_head.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion description "[Our results indicate that in patients with grade G3 adenocarcinoma, the expression of AT1-R significantly decreased in comparison with G1 patients (p?=?0.034), but the level of ER? was the highest in G2 and the lowest in G3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_provenance.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion evidence source_evidence_literature NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_provenance.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion SIO_000772 22170435 NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_provenance.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion wasDerivedFrom befree-20140225 NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_provenance.
- NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_assertion wasGeneratedBy ECO_0000203 NP653203.RAmUNvpCLzUZ4IMO9_UjbsyBXRs8NhEYf-hecYJ6aIwhs130_provenance.